国际麻醉学与复苏杂志   2011, Issue (1): 0-0
    
静脉输注利多卡因对腹部手术患者术后镇痛效果及肠道功能恢复的影响
马云, 邱晓东, 景亮1()
1.东南大学临床医学院
Effect of intravenous infusion of lidocaine to postoperative analgesic and the return of bowel function in patients underwent abdominal cavity surgery
 全文:
摘要:

摘 要: 目的 研究静脉输注利多卡因对开腹手术患者术后镇痛效果及肠功能恢复的影响。 方法 选择60名ASA I ~ III 级择期行腹部手术的患者,随机分为三组,每组20人: L1组、 L2组、 S组。采用双盲法,诱导时,L1组诱导时静注1.5 mg∙kg-1 利多卡因后按2 mg∙kg-1∙h-1的速度维持至术毕,术后以 0.5 mg∙kg-1∙h-1的速度持续输入48 h, L2组诱导时静注1.5 mg∙kg-1 利多卡因后按2 mg∙kg-1∙h-1的速度维持至术毕,术后以 0.25 mg∙kg-1∙h-1的速度持续输入48 h,对照组给予等体积的生理盐水。术中采用丙泊酚、瑞芬太尼全凭静脉麻醉。术后采用全自控式吗啡静脉镇痛。测量手术结束时、术后24 h、48 h利多卡因的血药浓度。记录手术时间、术中瑞芬太尼用量、术后2 h、6 h、12 h、24 h、48 h吗啡消耗量、PCA按压次数、静息及咳嗽时疼痛VAS评分、首次排气及排便时间。 结果 与S对照组相比,静脉输注利多卡因可减少患者术中瑞芬太尼的用量、术后48小时的吗啡消耗量及PCIA按压需求(P<0.05),促进术后早期排气排便(P<0.05)。手术结束时、术后24 h、48 h利多卡因血药浓度分别为L1组2.8±1.1 μg/ml、1.7±0.7 μg/ml、1.5±0.5 μg/ml,L2组2.6±1.2 μg/ml、1.1±0.4 μg/ml、0.9±0.3 μg/ml。结论 围术期静脉输注利多卡因可减少开腹手术患者术中阿片类药物用量,增强术后镇痛效果,促进患者术后肠道功能的恢复。

关键词: 利多卡因;术后镇痛;肠功能恢复
Abstract:

Abstract: Objective To assess the effect of intravenous low-dose lidocaine infusion on postoperative analgesic and the return of bowel function in patients underwent abdominal cavity surgery. Methods Sixty ASA I~III patients scheduled to undergo abdominal cavity surgery were randomly divided into groups L1、L2 and control group S. In group L1, 1.5 mg∙kg-1 lidocaine was injected during anesthesia induction, then 2 mg∙kg-1∙h-1 IV intraoperatively and 0.5 mg∙kg-1∙h-1 for 48 h postoperatively, in group L2, the same lidocaine application as group L1 except 0.25 mg∙kg-1∙h-1 IV for 48 h postoperatively, in group control, an equal volume of saline were given. Anesthesia was maintained by propofol and remifentanil. Postoperative analgesia was provided by only patient-controlled analgesia with morphine. Blood samples were drawn to measure plasma lidocaine concentrations at the end of surgery, 24 h and 48 h after operations. Postoperative pain was evaluated by visual analog score(VAS) , VAS was measured at rest and during coughing at 2、6、12、24、48 h postoperatively. Summary the consumption of morphine and number of PCA press times, record the times of first flatus and defecation. Results Contrast with the control group, lidocaine reduced remifentanil consumption during surgery as well as postoperative morphine consumption, and shorten times to first flatus and defecation. Corresponding plasma lidocaine concentrations at the end of surgery, 24 h and 48 h after operations were 2.8±1.1μg/ml、1.7±0.7μg/ml、1.5±0.5μg/ml in group L1 and 2.6±1.2μg/ml、1.1±0.4μg/ml、0.9±0.3μg/ml in group L2. Conclusion Intravenous lidocaine improves postoperative analgesia and bowel function recovery after abdominal cavity surgery and reduces opium consumption during surgery.

Key words: Lidocaine;Analgesic:postoperative;Bowel function recovery